To know the resistance status in Taiwan, an earlier study conducted by Dr. Tsai-ling Lauderdale analyzed the antimicrobial resistance trends in E. faecalis and E. faecium isolates (1696 and 452 isolates, respectively) collected from the Taiwan Surveillance of Antimicrobial Resistance program during 2004-2010. The most noteworthy change in susceptibilities of these two species was vancomycin resistance in E. f aecium, which increased from 0.3% in 2004 to 24.9% in 2010. Multidrug resistance was very common in both species even in isolates from outpatients (82.7% for E. faecalis and 98.1% for E. faecium), at rates similar to those from intensive care unit (ICU) and non-ICU patients (80.5–80.9% for E. faecalis and 97.2–98.6% for E. faecium). Almost all isolates were susceptible to linezolid and daptomycin. This nationwide surveillance revealed high multi-drug resistance rates for inpatient and community isolates of both species. To propose control strategies and prevent the rise of antibiotic resistance, continuous surveillance of antimicrobial resistance in enterococci, monitoring of use of antibiotics in human and veterinary medicine, and survey of community reservoirs of these multidrug-resistant organisms are warranted. (References: Harrison’s Infectious Diseases 2010; Diag Microbiol Infect Dis 2013: 75: 406–411)